Skip to main content
iCAD, Inc. (ICAD)
NASDAQ: ICAD · Real-Time Price · USD
1.545
-0.015 (-0.96%)
At close: Nov 20, 2024, 4:00 PM
1.580
+0.035 (2.27%)
After-hours: Nov 20, 2024, 6:49 PM EST

iCAD, Inc. Revenue

iCAD, Inc. had revenue of $4.22M in the quarter ending September 30, 2024, with 3.54% growth. This brings the company's revenue in the last twelve months to $18.94M, up 10.03% year-over-year. In the year 2023, iCAD, Inc. had annual revenue of $17.32M, down -12.54%.

Revenue (ttm)
$18.94M
Revenue Growth
+10.03%
P/S Ratio
2.15
Revenue / Employee
$274,493
Employees
69
Market Cap
40.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202317.32M-2.48M-12.54%
Dec 31, 202219.80M-13.84M-41.13%
Dec 31, 202133.64M3.94M13.27%
Dec 31, 202029.70M-1.64M-5.24%
Dec 31, 201931.34M5.72M22.32%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NeueHealth 996.89M
BioLineRx 17.05M
Accelerate Diagnostics 11.91M
Verrica Pharmaceuticals 9.21M
Omega Therapeutics 8.10M
LAVA Therapeutics 7.40M
HCW Biologics 3.50M
Envoy Medical 278.00K
Revenue Rankings

ICAD News

More News